* NeueHealth Inc NEUE.N NEUE.K is expected to show a
fall in
quarterly revenue when it reports results on May 8 for the
period ending March 31 2024
* The Doral Florida-based company is expected to report a
67.1% decrease in revenue to $248.509 million from $756.34
million a year ago, according to the mean estimate from 2
analysts, based on LSEG data.
* LSEG's mean analyst estimate for NeueHealth Inc is for a
loss
of $5.30 per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for NeueHealth
Inc is
$13.00, above its last closing price of $6.25.
This summary was machine generated May 6 at 15:34 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)